Continuation of the nuMoM2b Heart Health Study
At a glance
Conditions
NCT05472597
Where you'd take part
This study runs at 14 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Case Western Reserve University/The MetroHealth System
Cleveland, Ohiono site contact published
Christiana Care Health Services
Newark, Delawareno site contact published
Columbia University Medical Center
New York, New Yorkno site contact published
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvaniano site contact published
Indiana University
Indianapolis, Indianano site contact published
Intermountain Medical Center
Murray, Utahno site contact published
LDS Hospital
Salt Lake City, Utahno site contact published
Magee Womens Research Institute
Pittsburgh, Pennsylvaniano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- George Saade, MD · PRINCIPAL_INVESTIGATOR · Old Dominion University
- Phillip Greenland, MD · PRINCIPAL_INVESTIGATOR · Northwestern University
- Rebecca McNeil, PhD · PRINCIPAL_INVESTIGATOR · RTI International
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Incidence of hypertension (130/80 mmHg)Assessed during the HHS2 in-person visit, 8-16 years after the index pregnancy.
Measured blood pressure \> 130/80 mmHg, use of antihypertensive medication, or self-report of a hypertension clinical diagnosis
- Incidence of diabetesAssessed during the HHS2 in-person visit, 8-16 years after the index pregnancy.
Measured hemoglobin A1c GE 6.5%, fasting blood glucose GE 126 mg/dL, use of blood sugar lowering medication, or self-report of a diabetes clinical diagnosis
- Incidence of obesityAssessed during the HHS2 in-person visit, 8-16 years after the index pregnancy.
Measured BMI GE 30 kg/m\^2
- Incidence of metabolic syndromeAssessed during the HHS2 in-person visit, 8-16 years after the index pregnancy.
Per the American Heart Association standard definition: Any three of the following five - 1) waist circumference \> 35 inches (88 cm) for non-Asians and \> 31.5 inches (80 cm) for Asians; 2) triglycerides \> 150 mg/dL or medication treatment for high triglycerides; 3) high density lipoprotein (HDL) \< 50 mg/dL or medication treatment for low HDL; 4) a serum glucose ≥ 100 mg/dL or a diagnosis of diabetes mellitus; 5) systolic blood pressure (SBP) ≥ 130 mmHg or diastolic blood pressure (DBP) ≥ 85 mmHg, or medication treatment for hypertension.